Structures by: Burchell C. J.
Total: 23
[C24H20P]2.[(C2N2S2)2]Pd
[C24H20P]2.[(C2N2S2)2]Pd
Dalton transactions (Cambridge, England : 2003) (2004) 3 369-374
a=10.861(2)Å b=14.540(3)Å c=15.163(3)Å
α=88.894(11)° β=88.705(10)° γ=83.598(10)°
[C34H28FeP2].Pt.[C2N2S2]
[C34H28FeP2].Pt.[C2N2S2]
Dalton transactions (Cambridge, England : 2003) (2004) 3 369-374
a=9.3113(13)Å b=9.5996(13)Å c=18.070(2)Å
α=99.062(2)° β=95.808(2)° γ=101.906(2)°
C20H30Rh2.[C2N2S2]2.[CHCl3]2
C20H30Rh2.[C2N2S2]2.[CHCl3]2
Dalton transactions (Cambridge, England : 2003) (2004) 3 369-374
a=19.181(4)Å b=8.8430(19)Å c=21.576(5)Å
α=90.00° β=102.771(3)° γ=90.00°
Meso-5,5,7,12,12,14-Hexamethyl-1,4,8,11-tetraazacyclotetradecane--3,5- dinitrobenzoic acid(1/2)
C16H38N4,2(C7H3N2O6)
Acta Crystallographica Section B (2000) 56, 6 1054-1062
a=8.7336(3)Å b=10.9388(3)Å c=11.0284(3)Å
α=114.5800(17)° β=91.9660(18)° γ=111.6740(18)°
Meso-5,5,7,12,12,14-Hexamethyl-1,4,8,11-tetraazacyclotetradecane--5- hydroxyisophthalic acid--water (1/1/1)
C16H38N4,C8H4O5,H2O
Acta Crystallographica Section B (2000) 56, 6 1054-1062
a=11.8760(5)Å b=13.8395(6)Å c=15.8571(7)Å
α=90.00° β=90.00° γ=90.00°
Racemic-5,5,7,12,12,14-Hexamethyl-1,4,8,11-tetraazacyclotetradecane--5- hydroxyisophthalic acid--water (1/1/1)
C16H38N4,C8H4O5,H2O
Acta Crystallographica Section B (2000) 56, 6 1054-1062
a=16.0262(4)Å b=11.6461(3)Å c=15.7907(3)Å
α=90.00° β=118.6520(12)° γ=90.00°
Piperazine-ethane-1,2-diphosphonic acid (1/1)
C4H12N2,C2H6O6P2
Acta Crystallographica Section B (2001) 57, 1 95-102
a=7.3914(6)Å b=9.3343(7)Å c=9.3590(6)Å
α=90.00° β=107.291(4)° γ=90.00°
4,4'-trimethylenedipiperidine-ethane-1,2-diphosphonic acid-water (1/1/2.8).
(C13H28N2),(C2H6O6P2),2.8(H2O)
Acta Crystallographica Section B (2001) 57, 1 95-102
a=6.1218(2)Å b=20.6215(7)Å c=18.1831(7)Å
α=90.00° β=99.942(2)° γ=90.00°
1,4-Diazabicyclo[2.2.2]octane--3,5-dihydroxybenzoic acid--water (1/1/1)
C6H13N2,C7H5O4,H2O
Acta Crystallographica Section B (2001) 57, 3 329-338
a=9.4478(4)Å b=11.7644(4)Å c=25.9024(12)Å
α=90° β=101.969(2)° γ=90°
3,5-Dinitrobenzoic acid--1,4-diazabicyclo[2.2.2]octane--water (2/1/0.13)
C6H13N2,C7H4N2O6,C7H3N2O6,0.13(H2O)
Acta Crystallographica Section B (2001) 57, 2 201-212
a=11.6228(4)Å b=10.4320(3)Å c=19.6350(6)Å
α=90.00° β=109.6890(18)° γ=90.00°
3,5-Dinitrobenzoic acid--1,2-diaminoethane (2/1)
2(C7H3N2O6),C2H10N2
Acta Crystallographica Section B (2001) 57, 2 201-212
a=5.4549(2)Å b=10.6869(4)Å c=17.4420(6)Å
α=90.00° β=95.704(2)° γ=90.00°
3,5-Dinitrobenzoic acid--piperazine (2/1)
2(C7H3N2O6),C4H12N2
Acta Crystallographica Section B (2001) 57, 2 201-212
a=6.6970(5)Å b=9.1655(8)Å c=10.5942(9)Å
α=65.338(3)° β=85.985(4)° γ=69.313(3)°
3,5-Dinitrobenzoic acid--N,N,N',N'-tetramethylethylenediamine (2/1)
2(C7H3N2O6),C6H18N2
Acta Crystallographica Section B (2001) 57, 2 201-212
a=6.0665(2)Å b=9.0635(3)Å c=21.8452(6)Å
α=90.00° β=92.031(2)° γ=90.00°
3,5-Dinitrobenzoic acid--N,N'-dimethylpiperazine (2/1)
2(C7H3N2O6),C6H16N2
Acta Crystallographica Section B (2001) 57, 2 201-212
a=7.1399(2)Å b=21.1749(6)Å c=7.8255(2)Å
α=90.00° β=99.1990(18)° γ=90.00°
3,5-Dinitrobenzoic acid--1,2-bis(4'-pyridyl)ethane (2/1)
C12H13N2,C14H7N4O12
Acta Crystallographica Section B (2001) 57, 2 201-212
a=10.1344(6)Å b=4.9420(2)Å c=27.5984(14)Å
α=90.00° β=110.960(2)° γ=90.00°
3,5-Dinitrobenzoic acid--trans-1,2-bis(4'-pyridyl)ethene (2/1)
C12H12N2,2(C7H3N2O6)
Acta Crystallographica Section B (2001) 57, 2 201-212
a=4.7297(3)Å b=9.3973(6)Å c=14.8365(6)Å
α=104.528(3)° β=94.086(3)° γ=92.793(3)°
Piperazinee--3,5-dihydroxybenzoic acid--water (1/2/4)
C4H12N2,2(C7H5O4),4(H2O)
Acta Crystallographica Section B (2001) 57, 3 329-338
a=7.7793(3)Å b=8.1656(3)Å c=9.0662(4)Å
α=104.981(2)° β=97.134(2)° γ=98.066(2)°
1,2-Diaminoethane--3,5-dihydroxybenzoic acid--water (1/2/2)
C2H10N2,2(C7H5O4),2(H2O)
Acta Crystallographica Section B (2001) 57, 3 329-338
a=8.0804(3)Å b=10.6021(6)Å c=11.3988(6)Å
α=90.00° β=109.243(3)° γ=90.00°
4,4'-Trimethylenedipiperidine--benzene-1,2,4,5-tetracarboxylic acid--water (1/1/1)
C13H28N22,C10H4O82,H2O
Acta Crystallographica Section C (2001) 57, 1 92-94
a=10.5885(4)Å b=11.5840(6)Å c=11.8301(6)Å
α=61.453(2)° β=80.999(3)° γ=64.055(3)°
3,6,9,16,19,22-Hexa-azatricyclo[22.2.2.2^11,14^]triconta- 1(26),11(29),12,14(30),24,27-hexaene--3,5-dinitrobenzoic acid--methanol (1/4/2)
C24H42N64,4C7H3N2O6,2CH4O
Acta Crystallographica Section C (2001) 57, 1 88-91
a=24.6342(7)Å b=11.7501(2)Å c=21.4967(7)Å
α=90° β=102.3970(10)° γ=90°
Racemic 5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-- 1,3,5-benzenetricarboxylic acid--methanol--water (1/1/0.78/1.12)
C16H38N41,C9H4O61,0.78CH4O,1.12H2O
Acta Crystallographica Section C (2001) 57, 3 311-314
a=13.8921(9)Å b=15.3390(6)Å c=14.0209(8)Å
α=90.00° β=95.666(2)° γ=90.00°
1,4-Diazabicyclo[2.2.2]octane--5-hydroxyisophthalic acid (1/1)
C6H13N2,C8H5O5
Acta Crystallographica Section C (2000) 56, 9 1126-1128
a=17.3820(7)Å b=6.7257(3)Å c=23.9374(9)Å
α=90.00° β=95.368(2)° γ=90.00°
[C2N2S2].[C8H11P]2.Pt
[C2N2S2].[C8H11P]2.Pt
Dalton transactions (Cambridge, England : 2003) (2004) 3 369-374
a=33.846(10)Å b=11.431(7)Å c=11.030(7)Å
α=90.00° β=92.792(9)° γ=90.00°